Astrana Health, Inc. (ASTH) Q4 FY25 Earnings Call

Record 2025 execution and 2026 growth guidance are offset by Medicaid pressure and accounting-control remediation.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-03-02
Length52 minutes
EPS$0.54
Revenue$605.8M
Revenue consensus$930.5M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All ASTH earnings ยท Back to ASTH overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.